Bas van Driel, CEO
‘We care’ mantra spurs DFE Pharma’s drive towards excipient excellence
Company offers a comprehensive portfolio for oral solid dose and dry powder formulations, ranging from starch, lactose and microcrystalline cellulose to inhalants and superdisintegrant
Topic |
Germany Business Report 2017
Supported by
Discovery Reports
Bas van Driel, CEO